- Home
- SRRK vs DFH Comparison
SRRK vs DFH Comparison
Compare SRRK & DFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRRK
- DFH
- Stock Information
- Founded
- SRRK 2012
- DFH 2008
- Country
- SRRK United States
- DFH United States
- Employees
- SRRK N/A
- DFH N/A
- Industry
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- DFH Homebuilding
- Sector
- SRRK Health Care
- DFH Consumer Discretionary
- Exchange
- SRRK Nasdaq
- DFH Nasdaq
- Market Cap
- SRRK 2.8B
- DFH 3.1B
- IPO Year
- SRRK 2018
- DFH 2021
- Fundamental
- Price
- SRRK $26.49
- DFH $28.30
- Analyst Decision
- SRRK Strong Buy
- DFH Hold
- Analyst Count
- SRRK 7
- DFH 1
- Target Price
- SRRK $34.00
- DFH $38.00
- AVG Volume (30 Days)
- SRRK 984.5K
- DFH 438.5K
- Earning Date
- SRRK 11-12-2024
- DFH 10-31-2024
- Dividend Yield
- SRRK N/A
- DFH N/A
- EPS Growth
- SRRK N/A
- DFH 15.80
- EPS
- SRRK N/A
- DFH 3.03
- Revenue
- SRRK N/A
- DFH $4,028,851,000.00
- Revenue This Year
- SRRK N/A
- DFH $15.83
- Revenue Next Year
- SRRK N/A
- DFH N/A
- P/E Ratio
- SRRK N/A
- DFH $9.29
- Revenue Growth
- SRRK N/A
- DFH 8.59
- 52 Week Low
- SRRK $6.76
- DFH $23.46
- 52 Week High
- SRRK $35.38
- DFH $44.38
- Technical
- Relative Strength Index (RSI)
- SRRK 50.87
- DFH 34.60
- Support Level
- SRRK $25.86
- DFH $30.55
- Resistance Level
- SRRK $28.11
- DFH $33.26
- Average True Range (ATR)
- SRRK 1.68
- DFH 1.54
- MACD
- SRRK -0.92
- DFH -0.30
- Stochastic Oscillator
- SRRK 11.71
- DFH 5.97
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia. Geographically, the company operates in the United States. The company's product candidate is Apitegroma which is a selective, fully human, monoclonal antibody, with a mechanism of action that results in inhibition of the activation of the growth factor, myostatin, in skeletal muscle. Its other product comprises SRK-181, an inhibitor of the activation of latent transforming growth factor beta-1 ("TGFβ1"), for the treatment of cancers that are resistant to anti-PD-(L)1 antibody therapies.
About DFH Dream Finders Homes Inc.
Dream Finders Homes Inc is engaged in the home building business. It designs, builds, and sells homes in Jacksonville, Orlando, Denver, the Washington D.C. metropolitan area, and Austin. The company operates through six geographical divisions namely, Jacksonville, Orlando, Denver, Washington DC (Capital), and the Carolinas (H&H Homes), Jet Home Loans LLC. Jacksonville division generates majority of the revenue for the firm.